EssilorLuxottica, the eyewear giant that owns Ray-Ban, LensCrafters and dozens of other brands, faces turmoil as its top executives argue
PARIS—The eyewear giant that owns Ray-Ban, LensCrafters and dozens of other brands is in turmoil as a public fight broke out between top executives over control of the company, just six months after they created it in a merger of equals.
Shares of EssilorLuxottica SA, the world’s leading eyewear company with more than €16 billion in annual revenue, fell 6.6% on Thursday in Paris after a top executive, the Italian billionaire Leonardo Del Vecchio, accused other executives of violating the pact that created...
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
The Future of the Enterprise with Ray WangRay Wang of Constellation Research, talks with Workday’s Joe Korngiebel about how the open source/platform dichotomy leads to more innovation, how organizations need to think about their data to drive business outcomes, and where the industry is at in terms of AI maturity.
Consulte Mais informação »
Orangutan blinded after being shot dozens of times with air gunAn X-ray showed at least 74 air gun pellets in the orangutan, named Hope, including four in its left eyes and two in the right.
Consulte Mais informação »
How vision plans rig the eyewear market while keeping consumers in the dark'People tend to think of the vision plans offered by employers as being like any other health insurance. They’re not.' Davidlaz is out with his newest column on how the eyewear industry 'is characterized by consolidation, self-interest and price-fixing.'
Consulte Mais informação »
Private-equity giant TPG says it fired a top executive after he was caught in the college-admissions scandal, and it's letting investors pull moneyPrivate equity firm TPG has fired 'Bill' McGlashan after he was among dozens of people indicted by the FBI Tuesday in an alleged scheme to get students into elite colleges.
Consulte Mais informação »
BioScrip's stock soars after merger deal with Option Care, owned by Walgreens and Madison DearbornShares of BioScrip Inc. soared 32% toward a 4-year high in premarket trade Friday, after the company announced a deal to merge with privately held Option Care Enterprises Inc., a provider of home and alternate treatment site infusion therapy services owned by funds affiliated with Walgreens Boots Alliance Inc. and private-equity firm Madison Dearborn Partners LLC (MDP). BioScrip's stock is halted for news until 7:30 a.m. Eastern. Under terms of the agreement, BioScrip will issue new shares to Option Care's shareholder and Walgreens and MDP will own about 80% of the combined publicly traded company. BioScrip's market capitalization was about $446.9 million as of Thursday's close. "This is a compelling and complementary fit of two leading players in the U.S. infusion market," said BioScrip Chief Executive Daniel Greenleaf. "Together, we will be able to provide a diverse set of life-improving and cost-effective services to more patients across the United States." BioScrip's stock has rallied 31% over the past 12 months, while the SPDR Health Care Select Sector ETF has gained 6.9% and the Dow Jones Industrial Average has tacked on 3.4%.
Consulte Mais informação »
FIS and Worldpay agree on a $43bn mergerThe race to create a global payments giant is shifting up a gear
Consulte Mais informação »